Señalización PI3K / Akt / mTOR
Los inhibidores de la señalización PI3K/Akt/mTOR son compuestos que se dirigen a las vías de la fosfoinositida 3-cinasa (PI3K), la cinasa Akt y el blanco de la rapamicina en mamíferos (mTOR). Estas vías son reguladores críticos del crecimiento celular, la supervivencia, el metabolismo y la autofagia, lo que las convierte en objetivos clave en la investigación del cáncer y los trastornos metabólicos. Inhibir estas vías puede ayudar a controlar el crecimiento y la proliferación tumoral, ofreciendo potenciales estrategias terapéuticas para varios tipos de cáncer y otras enfermedades caracterizadas por una señalización celular desregulada. En CymitQuimica, ofrecemos una amplia selección de inhibidores de alta calidad de PI3K/Akt/mTOR para apoyar su investigación en oncología, señalización celular y enfermedades metabólicas.
Subcategorías de "Señalización PI3K / Akt / mTOR"
- AMPK(164 productos)
- ATM / ATR(75 productos)
- ADN-PK(50 productos)
- EGFR(610 productos)
- MELK(7 productos)
- PDK(13 productos)
- PI3K(237 productos)
- Quinasa S6(5 productos)
- gsk-3(107 productos)
- mTOR(164 productos)
Mostrar 2 subcategorías más
Se han encontrado 1025 productos para "Señalización PI3K / Akt / mTOR".
Ordenar por
Pureza (%)
0
100
|
0
|
50
|
90
|
95
|
100
NSC 228155
CAS:NSC 228155 is an activator of EGFR, binding to the sEGFR dimerization domain II and modulate EGFR tyrosine phosphorylation.Fórmula:C11H6N4O4SPureza:97.22%Forma y color:SolidPeso molecular:290.25Ref: TM-T6908
2mg34,00€5mg48,00€1mL*10mM (DMSO)50,00€10mg63,00€25mg117,00€50mg178,00€100mg334,00€200mg469,00€Naquotinib
CAS:Naquotinib (ASP8273) (ASP8273) is an orally available, mutant-selective and irreversible EGFR inhibitor; (IC50s: 8-33 nM and 230 nM toward EGFR mutants and EGFRFórmula:C30H42N8O3Pureza:97.49%Forma y color:SolidPeso molecular:562.71SB 216763
CAS:SB 216763 (SB216763) is an effective and specific GSK-3α/β inhibitor (IC50: 34.3 nM).Fórmula:C19H12Cl2N2O2Pureza:98.89% - 99.13%Forma y color:SolidPeso molecular:371.22Ref: TM-T3077
2mg37,00€5mg50,00€1mL*10mM (DMSO)50,00€10mg74,00€25mg124,00€50mg187,00€100mg315,00€500mg762,00€SU5214
CAS:SU5214 is a modulator of tyrosine kinase signal transduction.Fórmula:C16H13NO2Pureza:99.45% - 99.55%Forma y color:White SolidPeso molecular:251.2799WS3
CAS:WS3, a β cell proliferation inducer, regulates Erb3 binding protein-1 (EBP1) and the IκB kinase pathway.Fórmula:C28H30F3N7O3Pureza:97.93% - 99.94%Forma y color:SolidPeso molecular:569.58(E)-AG 556
CAS:AG 556 is a selective inhibitor of EGFR and blocks LPS-induced TNF-α production.Fórmula:C20H20N2O3Pureza:99.93%Forma y color:Light Yellow PowderPeso molecular:336.38Epitinib
CAS:Epitinib is an orally active, selective, blood-brain barrier crossing epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI).Fórmula:C24H26N6O2Forma y color:SolidPeso molecular:430.5WZ4002
CAS:WZ4002 is a mutant-selective EGFR inhibitor for EGFR(L858R) and EGFR(T790M) with IC50 of 2 nM/8 nM.Fórmula:C25H27ClN6O3Pureza:97.51%Forma y color:White SolidPeso molecular:494.97Ref: TM-T6238
2mg34,00€5mg49,00€1mL*10mM (DMSO)50,00€10mg70,00€25mg111,00€50mg177,00€100mg313,00€200mg464,00€Eganelisib
CAS:Eganelisib (IPI-549) is an inhibitor of PI3Kγ (IC50 = 16, 3,200, 3,500, and >8,400 nM for PI3Kγ, PI3Kα, PI3Kβ, and PI3Kδ, respectively)Fórmula:C30H24N8O2Pureza:98.92% - 99.28%Forma y color:SolidPeso molecular:528.56TMBIM6 antagonist-1
CAS:TMBIM6 antagonist-1 (BAX-inhibitor-1) is a bax inhibitorFórmula:C15H12N2O3Pureza:99.26%Forma y color:SolidPeso molecular:268.27LY2090314
CAS:LY2090314, a potent GSK-3α/β blocker (IC50: 1.5/0.9 nM), could boost platinum chemo. Tested in leukemia and advanced cancers.Fórmula:C28H25FN6O3Pureza:99.21% - 99.91%Forma y color:SolidPeso molecular:512.53Ref: TM-T1755
1mg34,00€2mg50,00€5mg90,00€1mL*10mM (DMSO)92,00€10mg131,00€25mg225,00€50mg369,00€100mg545,00€200mg777,00€TX1-85-1
CAS:TX1-85-1: irreversible Her3 inhibitor (IC50: 23 nM), degrades Her3 protein, disrupts signaling, binds Cys721 covalently.Fórmula:C32H36N8O3Pureza:97.16% - 98.72%Forma y color:SolidPeso molecular:580.68PD153035 hydrochloride
CAS:PD153035 hydrochloride (ZM 252868) is a effective and selective inhibitor of EGFR; few influence against FGFR, PGDFR, InsR, CSF-1, and Src.Fórmula:C16H15BrClN3O2Pureza:99.39% - ≥95%Forma y color:White SolidPeso molecular:396.67AMG 511
CAS:AMG 511: oral class I PI3K inhibitor (α, β, δ, γ Kis: 4, 6, 2, 1 nM), anti-tumor in mouse glioblastoma model, reduces p-Akt (Ser473).Fórmula:C22H28FN9O3SPureza:≥98%Forma y color:SolidPeso molecular:517.58EAI045
CAS:EAI045, an allosteric inhibitor, targets towards drug-resistant EGFR mutants but avoids the wild-type receptor.Fórmula:C19H14FN3O3SPureza:98.00% - 99.12%Forma y color:White SolidPeso molecular:383.4CUDC-101
CAS:CUDC-101 is a potent inhibitor of HDAC, EGFR and HER2 with IC50s of 4.4, 2.4 and 15.7 nM, respectively.Fórmula:C24H26N4O4Pureza:95.76% - 99.17%Forma y color:SolidPeso molecular:434.49PD153035
CAS:PD153035 (NSC-669364) hydrochloride is an effective and selective inhibitor of EGFR (Ki/IC50: 5.2/29 pM, in cell-free assays); little inhibitory against FGFR,Fórmula:C16H14BrN3O2Pureza:98.47% - 99.29%Forma y color:SolidPeso molecular:360.217BIO
CAS:7BIO triggers nonapoptotic death, blocks FLT3, DYRK1A/2, Aurora B/C kinases.Fórmula:C16H10BrN3O2Pureza:99.67%Forma y color:SolidPeso molecular:356.17Ref: TM-T22012
5mg43,00€1mL*10mM (DMSO)49,00€10mg60,00€25mg110,00€50mg170,00€100mg269,00€200mg380,00€GSK2636771
CAS:GSK2636771, an effective, specific, orally bioavailable, PI3Kβ inhibitor, has been used in cancer, lymphoma, solid neoplasm, recurrent solid neoplasm, andFórmula:C22H22F3N3O3Pureza:98.58% - ≥95%Forma y color:SolidPeso molecular:433.42Ref: TM-T2073
1mg40,00€2mg54,00€5mg84,00€1mL*10mM (DMSO)84,00€10mg142,00€25mg240,00€50mg340,00€100mg518,00€Alflutinib mesylate
CAS:Alflutinib mesylate (AST2818 mesylate) ,is an irreversible tyrosine kinase inhibitor that selectively inhibits EGFR mutations, especially T790M.Fórmula:C29H35F3N8O5SPureza:97.94% - 99.63%Forma y color:SolidPeso molecular:664.70
